Pulse Biosciences Shares Are Trading Lower After the Company Last Week Reported Q4 Financial Results. Also, the Company Announced Plans to Initiate a Rights Offering of up to $60 Million Worth of Units
Pulse Biosciences上週公佈第四季度財務業績後,該公司股價走低。此外,該公司還宣佈計劃啓動價值高達6000萬美元的單位的供股